Navigation Links
Molecular glue with new effect
Date:1/31/2008

This release is also available in German.

Ten years ago, researchers at the IMP - a basic research institute in Vienna - discovered a fundamental and amazingly plausible mechanism of cell division. They identified a protein complex, which, as a ring-shaped molecule, slides over the doubled chromosomes and holds precisely these together until the time they again separate. Because of its function as molecular glue, the protein complex was given the name cohesin.

In the working group of Jan-Michael Peters, Senior Scientist at the IMP, the molecule was continually monitored over the last ten years. Now Peters and his colleague, Kerstin Wendt, in cooperation with Katsuhiko Shirahige from the Tokyo Institute of Technology, were able to find evidence of another, also essential function of cohesin. As the researchers report in the online issue of the journal Nature, the molecule acts as a regulator of gene expression, and therefore plays an important role in the reading of genes. The molecule fulfills this function entirely independently of its thus far known activity.

Various inhibiting and promoting elements within the genome affect whether genes can be read in a particular situation and how intensively this process proceeds. Promoters initiate the reading process, whereas enhancers strengthen it, and silencers suppress it. The combination of these factors must be very finely tuned. The areas that are each influenced by the regulators are separated from each other by so-called insulators. It has now been ascertained at the IMP for the first time ever that cohesin is necessary for the function of such insulators.

This discovery not only enriches basic research by contributing to further fundamental knowledge. It should also be of medical interest: a number of rare but serious disorders can be traced back to mutations in cohesin. If the regulation of gene expression proceeds abnormally, developmental disorders are the result. The range of symptoms extends from subtle and hard-to-diagnose changes to massive, physical and cognitive impairments. One of the more well-known disorders of this kind is called Cornelia de Lange Syndrome. Affected persons suffer from numerous anomalies and malformations. A causative treatment is not available.

We cannot cure the disease, but we now know the molecular mechanisms that cause it. This helps us to better understand the disorder and its symptoms. Moreover, we expect that our findings will stimulate new exciting research, stated Jan-Michael Peters.

A valuable resource for this has already been created by the researchers in the course of their work: they have systematically searched the entire human genome for cohesin binding sites that is, the areas where cohesin is effective. Thus, the first genome-wide cohesin map in a mammalian species was developed. The database is open to the entire scientific community.


'/>"/>

Contact: Heidemarie Hurtl
hurtl@imp.ac.at
43-179-730-3625
Research Institute of Molecular Pathology
Source:Eurekalert

Related medicine news :

1. Story ideas from Molecular and Cellular Proteomics
2. Findings point to molecular Achilles heel for half of breast cancer tumors
3. The Journal of Biomolecular Screening garners Association TRENDS Bronze Award
4. Molecular pathway appears crucial in development of pulmonary fibrosis
5. New book presents comprehensive survey of research into the molecular basis of aging
6. Childrens Hospital researchers identify molecular switch that could save very young lives
7. In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly
8. Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
9. A molecular map for aging in mice
10. Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008
11. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha Chigurupati knows the meaning ... development and clinical trials, the founder of Chigurupati Technologies has invented India’s first ... approved ingredients that when infused into alcohol, protect the consumer’s liver and DNA, ...
(Date:2/16/2017)... , ... February 17, 2017 , ... Teaching nursing care ... program, now in development. ACE.P (pediatrics) is being created with the support of the ... of Vulnerable Populations , ACE.P will address what has been identified as a critical ...
(Date:2/16/2017)... Kisco, New York (PRWEB) , ... February 16, ... ... Hospital’s (NWH) nursing professionalism, teamwork and superiority in patient care, NWH has ... of the Commission on Magnet on Tuesday, January 31, 2017. The American Nurses ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... doegedevelopment.com/contact/ , doegedevelopment.com , David A Doege is excited to announce ... commercial tenant improvements, ground up new builds, design build, and site improvements. , ...
(Date:2/16/2017)... ... February 16, 2017 , ... A February 6 article ... freezing or CoolSculpting, noting that some 425,000 procedures were performed with the new technology ... clinic is, in fact, seeing a great deal of interest from area patients who ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... -- Express Scripts (NASDAQ: ESRX ) was recognized today by ... the Health Care: Pharmacy and Other Services category. "Express ... Admired Companies," said Tim Wentworth , CEO and President, Express ... our 26,000 employees to make medicine more affordable and accessible for ... ...
(Date:2/16/2017)... and SCOTTSDALE, Ariz. , Feb. 16, ... Health Information Exchange (HIE), announced today it is partnering with ... HealthInfoNet,s HIE contains 98% of all Maine ... Maine hospitals and over 500 ambulatory care ... Directors, HealthInfoNet plans to deploy Orion Health,s Amadeus , ...
(Date:2/16/2017)... and TEL AVIV, Israel ... a global interventional cardiology device company, today announced ... M.D., founder and past Chairman and Chief Executive ... created position of Executive Chairman of Medinol US ... Medinol,s global management in the areas of business ...
Breaking Medicine Technology: